Canonical text (the exact bytes fingerprinted)

TRUVACE RECORD VERSION
record: TRV-2026-0285
version: 1
kind: certified
reason: Certified into the record
timestamp: 2026-07-19T06:20:42.523724Z
status: published
lens: g_space
sector: health
headline: A CT-based deep learning model for the automated risk stratification of refractory Mycoplasma pneumoniae pneumonia in children
dek: The accurate identification of children with refractory Mycoplasma pneumoniae pneumonia (RMPP) remains challenging. This study aimed to develop a transformer-based model utilizing clinically indicated chest computed tomography (CT) to stratify pediatric RMPP risk at a critical decision point. Non-contrast chest CT data from a multicenter retrospective cohort of 1224 pediatric patients with Mycoplasma pneumoniae pneumonia who underwent clinically indicated CT were used to develop a transformer-based deep learning…
gain_title: A transformer-based deep learning framework using clinically indicated non-contrast chest CT stratified risk of refractory Mycoplasma pneumoniae pneumonia in children with AUCs around 0.89-0.90 on internal and external test cohorts.
problem_title: (none)
trace_subject: (none)
gain_reading: A transformer-based deep learning framework using clinically indicated non-contrast chest CT stratified risk of refractory Mycoplasma pneumoniae pneumonia in children with AUCs around 0.89-0.90 on internal and external test cohorts.
gain_evidence: The trans-DLF provides a streamlined and efficient approach to RMPP risk assessment in children who have already undergone clinically indicated chest CT and may support timely, evidence-based decision-making without additional tests
problem_reading: (none)
problem_evidence: (none)
quick_read: A multicenter retrospective study developed a transformer-based deep learning framework to stratify risk of refractory Mycoplasma pneumoniae pneumonia in children using non-contrast chest CTs obtained for clinical indications. The model was trained on 506 cases and tested internally on 139 and externally on 331 and 108 cases.

The approach matters because early identification of refractory disease can guide timely treatment decisions without extra testing, leveraging imaging already acquired. Uncertainty remains about prospective performance, applicability to children without a clinical CT indication, and integration into routine pediatric workflows.
limitation: Model was developed and tested only in a retrospective cohort of children who had already undergone clinically indicated chest CT, limiting generalizability to broader screening.
tag: Evidence-backed gain
key_points: Study used 1224 pediatric patients with Mycoplasma pneumoniae pneumonia across primary cohort of 785 and two external cohorts of 331 and 108. | Median age was 6.83 years and 609 (49.8%) were male. | Model was compared against a 3D-CNN, a clinical model, and a multimodal nomogram, significantly outperforming the clinical model. | Interpretability via Grad-CAM suggested predictions were influenced by consolidations.
rundown: Researchers built trans-DLF from non-contrast chest CTs in 1224 children with Mycoplasma pneumoniae pneumonia, splitting a primary cohort into training (n=506), validation (n=140), and internal testing (n=139) plus two external test sets. Performance was measured by AUC and benchmarked against a 3D-CNN, clinical model, and multimodal nomogram.

Results showed AUC 0.97 in training, 0.91 in validation, 0.90 in internal testing, and 0.89 in both external cohorts, with maintained performance in outpatient settings (AUC 0.87), good calibration and net clinical benefit. Grad-CAM analysis pointed to consolidations as influential features.
sources:
- peer_reviewed | BMC Medical Imaging | https://doi.org/10.1186/s12880-026-02590-y | 2026-07-17
prev: 0000000000000000000000000000000000000000000000000000000000000000

sha256

3ea3847461950a5ee8f7fb460a0b864b4be5b9cba26c39977fa85b7f4a758f98

previous

0000000000000000000000000000000000000000000000000000000000000000